ArticleMolecular medicine (Cambridge, Mass.)2026
Structural variations in evolutionary novel genomic regions: new insights into neurodevelopmental disorders by long-read DNA Sequencing.
Article in Molecular medicine (Cambridge, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundNeurodevelopmental disorders (NDDs) are highly diverse conditions often associated with genetic abnormalities. However, a large number of NDD cases remain undiagnosed despite thorough genetic testing using short-read sequencing and chromosomal microarray analysis. Emerging evidence indicates that structural variants (SVs) in evolutionarily new and human-specific genomic regions may be responsible for these unresolved cases.
methodsWe used Oxford Nanopore long-read DNA sequencing in six patients with unexplained NDDs who had previously tested negative for genetic mutations. Structural variants were identified and filtered based on their genomic location, regulatory potential, and expression in the central nervous system. Confirmatory fluorescence in situ hybridization (FISH) was performed. Additionally, immunohistochemical analysis of the candidate gene ANKRD20A1 was carried out to assess its spatiotemporal expression in the developing human brain. Interactome analysis was also performed to evaluate the functional connections of genes impacted by SVs.
resultsA total of twenty-six candidate SVs were found, including deletions, duplications, insertions, and inversions. Many of these SVs affect rapidly evolving gene families such as NBPF, TBC1D3, and RGPD, as well as regulatory elements in brain-expressed genes, suggesting their potential to disrupt brain development and lead to NDD. FISH analysis confirmed several large SVs. Patient-specific interactome maps showed that most RGPD-disrupted genes create extensive interactions. Immunohistochemical analysis revealed that ANKRD20A1, a candidate gene, is dynamically expressed during midfetal human cortical development, suggesting its involvement in neurodevelopmental events.
conclusionOur findings highlight the crucial role of long-read DNA sequencing in uncovering concealed structural variants within recently evolved genomic regions. These SVs may contribute to the development of NDDs by disrupting coding sequences, regulatory elements, or complex gene networks. This study supports integrating long-read sequencing into research workflows.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.